Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.
Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- Check5 days agoChange DetectedThe website has updated its results by removing estimated timestamps and now displays the actual 'Results First Posted' and 'Last Update Posted' dates.SummaryDifference0.3%
- Check12 days agoChange DetectedNew results have been posted regarding the efficacy and safety of Tamibarotene in treating transfusion-dependent LR-MDS and AML, including detailed definitions of response rates and adverse events, while previous submissions have been removed.SummaryDifference48%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference3%
- Check41 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.6%
Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.